Through a series of analyses, we found that nine CRLs (AC002128.2, AC002563.1, AC009237.14, AC048337.1, AC145423.1, AL117336.1, AP001542.3, ATP2A1-AS1, and LINC00426) could be used as prognostic biomarkers for CESC patients, and the constructed risk model using those nine CRLs could better predict the prognosis of CESC. This evidence concerns the gene ATP2A1 and cervical squamous cell carcinoma.